Plain Language Summary of First-Line Amivantamab-Lazertinib in Previously Untreated High-Risk EGFR-altered Non-Small-cell Lung Cancer in MARIPOSA.
Future oncology (London, England)(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Future oncology (London, England)(2025)